BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 17993408)

  • 1. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S; Yen Y; Ann D; Wong DT
    Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human saliva proteome analysis and disease biomarker discovery.
    Hu S; Loo JA; Wong DT
    Expert Rev Proteomics; 2007 Aug; 4(4):531-8. PubMed ID: 17705710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer biomarkers: current issues and future directions.
    Jain KK
    Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary proteomics in biomedical research.
    Zhang A; Sun H; Wang P; Wang X
    Clin Chim Acta; 2013 Jan; 415():261-5. PubMed ID: 23146870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative oncoproteomics strategies for anticancer drug discovery.
    Liu R; Wang K; Yuan K; Wei Y; Huang C
    Expert Rev Proteomics; 2010 Jun; 7(3):411-29. PubMed ID: 20536311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human saliva proteome analysis.
    Hu S; Loo JA; Wong DT
    Ann N Y Acad Sci; 2007 Mar; 1098():323-9. PubMed ID: 17435138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How molecular profiling could revolutionize drug discovery.
    Stoughton RB; Friend SH
    Nat Rev Drug Discov; 2005 Apr; 4(4):345-50. PubMed ID: 15789121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer proteomics and its application to discovery of therapy response markers in human cancer.
    Smith L; Lind MJ; Welham KJ; Cawkwell L;
    Cancer; 2006 Jul; 107(2):232-41. PubMed ID: 16752413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced proteomic technologies for cancer biomarker discovery.
    Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
    Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive cancer detection: strategies for the identification of novel cancer markers.
    Sorio C; Mauri P; Pederzoli P; Scarpa A
    IUBMB Life; 2006 Apr; 58(4):193-8. PubMed ID: 16754296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential uses of human salivary protein and peptide analysis in the diagnosis of disease.
    Al Kawas S; Rahim ZH; Ferguson DB
    Arch Oral Biol; 2012 Jan; 57(1):1-9. PubMed ID: 21774913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectrometry: uncovering the cancer proteome for diagnostics.
    van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
    Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.